Michael W. Climo

4.2k citations

42 papers · 3.0k indexed · 1 hit paper · h-index 29

Infectious Diseases top 0.5%
Clinical Biochemistry top 0.2%
Epidemiology top 5%
Molecular Biology
Critical Care and Intensive Care Medicine top 1%

Co-authors: Gordon L. Archer Edward S. Wong Roberto L. Patron Trish M. Perl David K. Warren Kent A. Sepkowitz Loreen A. Herwaldt John A. Jernigan
Topics: Antimicrobial Resistance in Staphylococcus (30 papers)Bacterial Identification and Susceptibility Testing (21 papers)Clostridium difficile and Clostridium perfringens research (9 papers)
Cited by: Applied Microbiology and Biotechnology Clinical Biochemistry Infectious Diseases
Journals: New England Journal of Medicine Annals of Internal Medicine Clinical Infectious Diseases
Partner nations: United States Netherlands Philippines

In The Last Decade

Michael W. Climo

42 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Daily Chlorhexidine Bathing on Hospital-Acquired Infection

2013 412 citations Michael W. Climo, Deborah S. Yokoe et al. profile →

Peers

Countries citing papers authored by Michael W. Climo

Since Specialization

Citations

This map shows the geographic impact of Michael W. Climo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Climo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Climo more than expected).

Fields of papers citing papers by Michael W. Climo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Climo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Climo. The network helps show where Michael W. Climo may publish in the future.

Co-authorship network of co-authors of Michael W. Climo

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Climo. A scholar is included among the top collaborators of Michael W. Climo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Climo. Michael W. Climo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence 2022 ·Contemporary Clinical Trials ·Stuart Johnson,Dale N. Gerding,Xue Li,Domenic J. Reda,Curtis J. Donskey,Kalpana Gupta,Matthew Bidwell Goetz,Michael W. Climo,Fred M. Gordin,Robert Ringer,Neil F. Johnson,Michelle J. Johnson,Lawrence A. Calais,(unknown),Ling Ge,(unknown)	2
2	Evaluation of Postprescription Review and Feedback as a Method of Promoting Rational Antimicrobial Use: A Multicenter Intervention 2012 ·Infection Control and Hospital Epidemiology ·Sara E. Cosgrove,Susan K. Seo,Maureen Bolon,Kent A. Sepkowitz,Michael W. Climo,Daniel J. Diekema,Kathleen Speck,Vidhya Gunaseelan,Gary A. Noskin,Loreen A. Herwaldt,Edward S. Wong,Trish M. Perl	66
3	USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections? 2011 ·Diagnostic Microbiology and Infectious Disease ·Kristen Kreisel,O. Colin Stine,J. Kristie Johnson,Eli N. Perencevich,Michelle Shardell,Alan J. Lesse,Fred M. Gordin,Michael W. Climo,Mary‐Claire Roghmann	32
4	Assessment of the 48-Hour Rule for Identifying Community-Associated Methicillin-Resistant Staphylococcus aureus Infection Complicated by Bacteremia 2010 ·Infection Control and Hospital Epidemiology ·Kristen Kreisel,Mary‐Claire Roghmann,Michelle Shardell,O. Colin Stine,Eli N. Perencevich,Alan J. Lesse,Fred M. Gordin,Michael W. Climo,(unknown)	2
5	Illicit Drug Use and Risk for USA300 Methicillin-ResistantStaphylococcus aureusInfections with Bacteremia 2010 ·Emerging infectious diseases ·Kristen Kreisel,J. Kristie Johnson,O. Colin Stine,Michelle Shardell,Eli N. Perencevich,Alan J. Lesse,Fred M. Gordin,Michael W. Climo,Mary‐Claire Roghmann	6
6	The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial* 2009 ·Critical Care Medicine ·Michael W. Climo,Kent A. Sepkowitz,Gianvincenzo Zuccotti,Victoria J. Fraser,David K. Warren,Trish M. Perl,Kathleen Speck,John A. Jernigan,Jaime R. Robles,Edward S. Wong	221
7	Improved Surveillance for Surgical Site Infections after Orthopedic Implantation Procedures: Extending Applications for Automated Data 2009 ·Clinical Infectious Diseases ·Maureen Bolon,David C. Hooper,Kurt Stevenson,(unknown),Margaret A. Olsen,Loreen A. Herwaldt,Gary A. Noskin,Victoria J. Fraser,Michael W. Climo,Yosef Khan,Johanna Vostok,Deborah S. Yokoe	75
8	Lack of Relationship between Purine Biosynthesis and Vancomycin Resistance in Staphylococcus aureus : a Cautionary Tale for Microarray Interpretation 2007 ·Antimicrobial Agents and Chemotherapy ·Paige M. Fox,Michael W. Climo,Gordon L. Archer	18
9	Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force 2007 ·American Journal of Infection Control ·Stephen G. Weber,Susan S. Huang,Shannon Oriola,W. Charles Huskins,Gary A. Noskin,Kathleen Harriman,Russell N. Olmsted,Marc J. M. Bonten,Tammy Lundstrom,Michael W. Climo,Mary‐Claire Roghmann,Cathryn Murphy,Tobi Karchmer	94
10	Improving Methicillin‐ResistantStaphylococcus aureusSurveillance and Reporting in Intensive Care Units 2007 ·The Journal of Infectious Diseases ·Susan S. Huang,Sheryl L. Rifas‐Shiman,David K. Warren,Victoria J. Fraser,Michael W. Climo,Edward S. Wong,Sara E. Cosgrove,Trish M. Perl,Jean M. Pottinger,Loreen A. Herwaldt,John A. Jernigan,(unknown),Daniel J. Diekema,Virginia L. Hinrichsen,Deborah S. Yokoe,Richard Platt	86
11	Selective Use of Intranasal Mupirocin and Chlorhexidine Bathing and the Incidence of Methicillin-Resistant Staphylococcus aureus Colonization and Infection Among Intensive Care Unit Patients 2007 ·Infection Control and Hospital Epidemiology ·(unknown),(unknown),Jerome J. Federspiel,Steve Kritchevsky,Edward S. Wong,Michael W. Climo	106
12	Legislative Mandates for Use of Active Surveillance Cultures to Screen for Methicillin-ResistantStaphylococcus aureusand Vancomycin-Resistant Enterococci: Position Statement From the Joint SHEA and APIC Task Force 2007 ·Infection Control and Hospital Epidemiology ·Stephen G. Weber,Susan S. Huang,Shannon Oriola,W. Charles Huskins,Gary A. Noskin,Kathleen Harriman,Russell N. Olmsted,Marc J. M. Bonten,Tammy Lundstrom,Michael W. Climo,Mary‐Claire Roghmann,Cathryn Murphy,Tobi Karchmer	85
13	Preventing Catheter-Associated Bloodstream Infections: A Survey of Policies for Insertion and Care of Central Venous Catheters From Hospitals in the Prevention Epicenter Program 2006 ·Infection Control and Hospital Epidemiology ·David K. Warren,Deborah S. Yokoe,Michael W. Climo,Loreen A. Herwaldt,Gary A. Noskin,Gianvincenzo Zuccotti,Jerome I. Tokars,Trish M. Perl,Victoria J. Fraser	46
14	A Multicenter Intervention to Prevent Catheter-Associated Bloodstream Infections 2006 ·Infection Control and Hospital Epidemiology ·David K. Warren,Sara E. Cosgrove,Daniel J. Diekema,Gianvincenzo Zuccotti,Michael W. Climo,Maureen Bolon,Jerome I. Tokars,Gary A. Noskin,Edward S. Wong,Kent A. Sepkowitz,Loreen A. Herwaldt,Trish M. Perl,Steven L. Solomon,Victoria J. Fraser	105
15	Varying Rates of Clostridium Difficile-Associated Diarrhea at Prevention Epicenter Hospitals 2005 ·Infection Control and Hospital Epidemiology ·(unknown),Michael W. Climo,Daniel J. Diekema,Victoria J. Fraser,Loreen A. Herwaldt,Susan Marino,Gary A. Noskin,Trish M. Perl,Xiaoyan Song,Jerome I. Tokars,David K. Warren,Edward S. Wong,Deborah S. Yokoe,(unknown),Kent A. Sepkowitz	35
16	Prevalence of the Use of Central Venous Access Devices Within and Outside of the Intensive Care Unit: Results of a Survey Among Hospitals in the Prevention Epicenter Program of the Centers for Disease Control and Prevention 2003 ·Infection Control and Hospital Epidemiology ·Michael W. Climo,Daniel J. Diekema,David K. Warren,Loreen A. Herwaldt,Trish M. Perl,Lance R. Peterson,(unknown),Connie Price,Kent A. Sepkowitz,Steve Solomon,(unknown),Victoria J. Fraser,Edward S. Wong	116
17	Staphylococcus aureus carriage and health care-acquired infection 2002 ·Current Infectious Disease Reports ·(unknown),Michael W. Climo	4
18	Combinations of Lysostaphin with β-Lactams Are Synergistic against Oxacillin-Resistant Staphylococcus epidermidis 2002 ·Antimicrobial Agents and Chemotherapy ·(unknown),Gordon L. Archer,Michael W. Climo	56
19	Seeking Vancomycin Resistant Staphylococcus aureus among Patients with Vancomycin-Resistant Enterococci 1999 ·Clinical Infectious Diseases ·(unknown),Michael W. Climo,(unknown),Michael B. Edmond,Richard P. Wenzel	42
20	An Outbreak of Pseudomonas aeruginosa Related to Contaminated Urodynamic Equipment 1997 ·Infection Control and Hospital Epidemiology ·Michael W. Climo,(unknown),Edward S. Wong	24

About Michael W. Climo

Michael W. Climo is a scholar working on Clinical Biochemistry, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 42 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (30 papers), Bacterial Identification and Susceptibility Testing (21 papers) and Clostridium difficile and Clostridium perfringens research (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (351 citations), Clinical Biochemistry (815 citations) and Infectious Diseases (1.8k citations). Michael W. Climo has collaborated with scholars based in United States, Netherlands and Philippines. Frequent co-authors include Gordon L. Archer, Edward S. Wong, Roberto L. Patron, Trish M. Perl, David K. Warren, Kent A. Sepkowitz, Loreen A. Herwaldt, John A. Jernigan, Victoria J. Fraser and Deborah S. Yokoe. Their work appears in journals such as New England Journal of Medicine, Annals of Internal Medicine and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact